Fresenius Historical Balance Sheet

FMS Stock

USD 20.93 0.44 2.06%

Trend analysis of Fresenius Medical Care balance sheet accounts such as Short and Long Term Debt Total of 6.2 B or Other Current Liab of 3.8 B provides information on Fresenius Medical's total assets, liabilities, and equity, which is the actual value of Fresenius Medical Care to its prevalent stockholders. By breaking down trends over time using Fresenius Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Fresenius Medical Care latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fresenius Medical Care is a good buy for the upcoming year.

Fresenius Medical Inventory

2.29 Billion

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Fresenius Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Fresenius Medical Care at a specified time, usually calculated after every quarter, six months, or one year. Fresenius Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Fresenius Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Fresenius currently owns. An asset can also be divided into two categories, current and non-current.

Fresenius Medical Balance Sheet Chart

At this time, Fresenius Medical's Intangible Assets are comparatively stable compared to the past year. Other Liabilities is likely to gain to about 3.2 B in 2024, whereas Short and Long Term Debt Total is likely to drop slightly above 6.2 B in 2024.

Common Stock Shares Outstanding Total Assets Short Long Term Debt Total Other Current Liab Non Current Assets Total Cash And Equivalents

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Fresenius Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Fresenius Medical Care books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Fresenius Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Fresenius Medical Care current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fresenius Medical Care. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2021	2022	2023	2024 (projected)
Short and Long Term Debt Total	13.3B	13.2B	12.1B	6.2B
Total Assets	34.4B	35.8B	33.9B	18.7B

Short Long Term Debt Total Total Assets

Fresenius Medical balance sheet Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Common Stock Shares Outstanding		-0.56	-0.65	-0.67	-0.54	-0.49	-0.58	-0.66	-0.55	-0.36	-0.37	-0.61	-0.62	-0.41	-0.18	0.18	-0.59	-0.68	0.01	-0.59	-0.6	-0.55	-0.36	-0.5	0.0	-0.11
Total Assets	-0.56		0.97	0.67	0.94	0.98	0.62	0.94	0.87	0.96	0.67	1.0	0.62	0.73	0.9	0.56	0.94	0.82	-0.25	0.86	0.99	0.4	0.96	0.77	-0.34	0.51
Short Long Term Debt Total	-0.65	0.97		0.63	0.89	0.91	0.63	0.99	0.81	0.89	0.55	0.98	0.66	0.61	0.82	0.45	0.97	0.78	-0.17	0.84	0.99	0.38	0.87	0.75	-0.26	0.42
Other Current Liab	-0.67	0.67	0.63		0.76	0.69	0.72	0.58	0.81	0.58	0.82	0.67	0.48	0.81	0.45	0.16	0.52	0.88	0.1	0.8	0.64	0.69	0.63	0.72	0.04	0.05
Total Current Liabilities	-0.54	0.94	0.89	0.76		0.96	0.63	0.84	0.84	0.9	0.77	0.94	0.58	0.8	0.83	0.45	0.8	0.79	-0.14	0.92	0.92	0.36	0.92	0.92	-0.21	0.37
Total Stockholder Equity	-0.49	0.98	0.91	0.69	0.96		0.59	0.86	0.86	0.97	0.75	0.97	0.58	0.8	0.91	0.56	0.88	0.81	-0.29	0.88	0.95	0.35	0.97	0.8	-0.37	0.53
Property Plant And Equipment Net	-0.58	0.62	0.63	0.72	0.63	0.59		0.62	0.8	0.57	0.61	0.63	0.06	0.66	0.52	0.43	0.57	0.79	-0.19	0.6	0.62	0.86	0.57	0.61	-0.2	0.33
Net Debt	-0.66	0.94	0.99	0.58	0.84	0.86	0.62		0.77	0.85	0.45	0.96	0.66	0.53	0.78	0.44	0.97	0.75	-0.14	0.8	0.97	0.37	0.82	0.69	-0.23	0.4
Retained Earnings	-0.55	0.87	0.81	0.81	0.84	0.86	0.8	0.77		0.86	0.81	0.86	0.49	0.88	0.8	0.6	0.79	0.97	-0.29	0.78	0.85	0.68	0.85	0.66	-0.35	0.5
Accounts Payable	-0.36	0.96	0.89	0.58	0.9	0.97	0.57	0.85	0.86		0.67	0.94	0.5	0.74	0.97	0.71	0.89	0.78	-0.34	0.8	0.94	0.35	0.98	0.7	-0.44	0.61
Cash	-0.37	0.67	0.55	0.82	0.77	0.75	0.61	0.45	0.81	0.67		0.64	0.35	0.99	0.59	0.33	0.45	0.78	-0.25	0.72	0.6	0.52	0.74	0.7	-0.31	0.35
Non Current Assets Total	-0.61	1.0	0.98	0.67	0.94	0.97	0.63	0.96	0.86	0.94	0.64		0.65	0.71	0.87	0.51	0.95	0.82	-0.24	0.87	1.0	0.4	0.93	0.77	-0.32	0.5
Non Currrent Assets Other	-0.62	0.62	0.66	0.48	0.58	0.58	0.06	0.66	0.49	0.5	0.35	0.65		0.39	0.36	-0.07	0.64	0.55	0.04	0.65	0.65	-0.03	0.48	0.45	-0.06	0.1
Cash And Short Term Investments	-0.41	0.73	0.61	0.81	0.8	0.8	0.66	0.53	0.88	0.74	0.99	0.71	0.39		0.67	0.43	0.54	0.84	-0.3	0.74	0.67	0.55	0.79	0.7	-0.35	0.43
Net Receivables	-0.18	0.9	0.82	0.45	0.83	0.91	0.52	0.78	0.8	0.97	0.59	0.87	0.36	0.67		0.83	0.84	0.67	-0.37	0.69	0.88	0.28	0.95	0.62	-0.46	0.63
Common Stock Total Equity	0.18	0.56	0.45	0.16	0.45	0.56	0.43	0.44	0.6	0.71	0.33	0.51	-0.07	0.43	0.83		0.55	0.45	-0.3	0.25	0.54	0.32	0.69	0.23	-0.35	0.54
Non Current Liabilities Total	-0.59	0.94	0.97	0.52	0.8	0.88	0.57	0.97	0.79	0.89	0.45	0.95	0.64	0.54	0.84	0.55		0.76	-0.26	0.73	0.97	0.38	0.86	0.58	-0.35	0.53
Inventory	-0.68	0.82	0.78	0.88	0.79	0.81	0.79	0.75	0.97	0.78	0.78	0.82	0.55	0.84	0.67	0.45	0.76		-0.2	0.79	0.81	0.72	0.78	0.62	-0.25	0.39
Other Current Assets	0.01	-0.25	-0.17	0.1	-0.14	-0.29	-0.19	-0.14	-0.29	-0.34	-0.25	-0.24	0.04	-0.3	-0.37	-0.3	-0.26	-0.2		-0.08	-0.23	-0.09	-0.27	0.01	0.95	-0.93
Other Stockholder Equity	-0.59	0.86	0.84	0.8	0.92	0.88	0.6	0.8	0.78	0.8	0.72	0.87	0.65	0.74	0.69	0.25	0.73	0.79	-0.08		0.84	0.31	0.78	0.88	-0.17	0.27
Total Liab	-0.6	0.99	0.99	0.64	0.92	0.95	0.62	0.97	0.85	0.94	0.6	1.0	0.65	0.67	0.88	0.54	0.97	0.81	-0.23	0.84		0.39	0.93	0.74	-0.32	0.49
Property Plant And Equipment Gross	-0.55	0.4	0.38	0.69	0.36	0.35	0.86	0.37	0.68	0.35	0.52	0.4	-0.03	0.55	0.28	0.32	0.38	0.72	-0.09	0.31	0.39		0.38	0.26	-0.11	0.22
Total Current Assets	-0.36	0.96	0.87	0.63	0.92	0.97	0.57	0.82	0.85	0.98	0.74	0.93	0.48	0.79	0.95	0.69	0.86	0.78	-0.27	0.78	0.93	0.38		0.72	-0.36	0.54
Short Term Debt	-0.5	0.77	0.75	0.72	0.92	0.8	0.61	0.69	0.66	0.7	0.7	0.77	0.45	0.7	0.62	0.23	0.58	0.62	0.01	0.88	0.74	0.26	0.72		-0.02	0.14
Intangible Assets	0.0	-0.34	-0.26	0.04	-0.21	-0.37	-0.2	-0.23	-0.35	-0.44	-0.31	-0.32	-0.06	-0.35	-0.46	-0.35	-0.35	-0.25	0.95	-0.17	-0.32	-0.11	-0.36	-0.02		-0.94
Common Stock	-0.11	0.51	0.42	0.05	0.37	0.53	0.33	0.4	0.5	0.61	0.35	0.5	0.1	0.43	0.63	0.54	0.53	0.39	-0.93	0.27	0.49	0.22	0.54	0.14	-0.94

Click cells to compare fundamentals

Fresenius Medical Account Relationship Matchups

Fresenius Medical balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	302.7M	294.3M	293.1M	293.2M	293.4M	405.8M
Total Assets	32.9B	31.7B	34.4B	35.8B	33.9B	18.7B
Short Long Term Debt Total	13.8B	12.4B	13.3B	13.2B	12.1B	6.2B
Other Current Liab	2.7B	3.0B	3.3B	3.4B	3.6B	3.8B
Total Current Liabilities	7.0B	6.2B	7.3B	6.5B	6.1B	3.6B
Total Stockholder Equity	13.2B	12.3B	14.0B	15.4B	13.6B	7.8B
Property Plant And Equipment Net	8.5B	4.1B	4.3B	4.2B	7.5B	7.8B
Net Debt	12.8B	11.3B	11.8B	11.9B	10.6B	5.7B
Retained Earnings	9.5B	10.3B	10.8B	10.7B	10.9B	11.5B
Accounts Payable	835.2M	827.4M	857.5M	931.3M	885.1M	550.9M
Cash	1.0B	1.1B	1.5B	1.3B	1.4B	1.5B
Non Current Assets Total	25.8B	24.4B	26.4B	27.6B	25.2B	13.8B
Non Currrent Assets Other	752.5M	4.8B	5.2B	5.0B	223.6M	212.4M
Cash And Short Term Investments	1.1B	1.2B	1.6B	1.4B	1.5B	1.6B
Net Receivables	4.0B	3.6B	3.9B	4.0B	4.1B	2.6B
Common Stock Total Equity	308.1M	307.9M	304.4M	292.9M	336.8M	304.7M
Liabilities And Stockholders Equity	32.9B	31.7B	34.4B	35.8B	33.9B	18.7B
Non Current Liabilities Total	12.7B	13.2B	13.1B	13.8B	13.0B	7.2B
Inventory	1.7B	1.9B	2.0B	2.3B	2.2B	2.3B
Other Current Assets	320.7M	455.7M	342.9M	351.1M	332.6M	348.1M
Other Stockholder Equity	4.5B	4.0B	4.2B	4.8B	3.4B	3.2B
Total Liab	19.7B	19.4B	20.4B	20.3B	19.1B	10.8B
Property Plant And Equipment Gross	8.5B	8.2B	4.3B	4.2B	17.9B	17.0B
Total Current Assets	7.2B	7.3B	8.0B	8.2B	8.7B	4.9B
Accumulated Other Comprehensive Income	(1.0B)	(2.2B)	(1.3B)	(388.5M)	(975.2M)	(926.4M)
Short Term Debt	3.3B	1.7B	2.6B	2.0B	1.6B	1.1B
Intangible Assets	1.4B	1.4B	1.5B	1.5B	1.4B	1.7B
Common Stock	304.4M	292.9M	293.0M	293.4M	337.4M	258.6M
Current Deferred Revenue	201.0M	606.3M	518.0M	105.7M	85.8M	81.5M
Other Liab	2.1B	2.5B	2.4B	2.7B	3.1B	3.2B
Other Assets	1.1B	1.1B	1.2B	1.1B	1.3B	1.4B
Long Term Debt	6.5B	6.8B	6.6B	7.2B	7.0B	5.7B
Property Plant Equipment	8.5B	8.2B	8.6B	8.3B	9.6B	10.1B
Good Will	14.0B	13.0B	14.4B	15.8B	14.7B	13.9B
Short Term Investments	133.3M	161.7M	136.4M	170.0M	136.3M	140.2M
Net Tangible Assets	(3.5B)	(3.1B)	(3.1B)	(3.3B)	(3.8B)	(4.0B)
Long Term Investments	696.9M	761.1M	786.9M	773.7M	1.3B	853.1M
Short Long Term Debt	2.6B	1.1B	1.9B	1.4B	944.6M	1.7B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fresenius Stock Analysis

When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fresenius Historical Balance Sheet

Fresenius Medical Inventory

2.29 Billion

About Fresenius Balance Sheet Analysis

Fresenius Medical Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Non Current Assets Total

Fresenius Medical balance sheet Correlations

Fresenius Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Fresenius Medical balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fresenius Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Total Liab	+ 1.0	Non Current Assets Total
Total Liab	+ 0.99	Total Assets
Net Debt	+ 0.99	Short Long Term Debt Total
Total Liab	+ 0.99	Short Long Term Debt Total
Cash And Short Term Investments	+ 0.99	Cash

Common Stock	- 0.94	Intangible Assets
Common Stock	- 0.93	Other Current Assets
Inventory	- 0.68	Common Stock Shares Outstanding
Other Current Liab	- 0.67	Common Stock Shares Outstanding
Net Debt	- 0.66	Common Stock Shares Outstanding
Short Long Term Debt Total	- 0.65	Common Stock Shares Outstanding